Business Practice

A case study involving the formulation development of a monoclonal antibody is presented to detail the utility and potential limitations of DSC in support of preformulation for a variety of protein products.

Sitting Down With... John Talley, Chief Scientific Officer at Euclises Pharmaceuticals, St. Louis, USA.

How can the pharma industry capitalize on the growth potential of emerging markets?

Grant Lindman is director of Eli Lilly’s global anticounterfeiting operations and is passionate about fighting fake medicines.

Recently, Tim Mackey and colleagues examined the extent to which counterfeit drugs had penetrated global legitimate supply chains.

Two antibody samples were characterized using column calibration and multi-detection SEC, and the results compared...

This application note describes how and when can kinetic information be retrieved from ITC power curves.

The EMA fights to reinstate its former executive director – and the FDA’s new leader is still unconfirmed

Mislabeled, substandard or falsified medicines are the perfect opportunity for criminals looking for low risks and high rewards.

Is it time to update your resume and fine-tune your interview skills?